TLR7-driven B cells have an abnormal immune function in MS, however, thymosin-α1 (Tα1) improved this dysregulation by reducing the production of IL-6, IL-8 and IL-1β and increasing IL-10 and IL-35 secretion (82). This evidence concerns the gene IL10 and myeloid sarcoma.